All Stories

  1. Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

    Article • Breast Cancer Targets and Therapy, December 2017, Dove Medical Press

    Mekonnen Sisay, Dumessa Edessa